SCHEDULE: River Global Investors Discloses 5.2% MAXCYTE Stake

River Global Investors LLP has disclosed a 5.1568% beneficial ownership stake in MAXCYTE, INC., acquiring over 5.4 million equity shares.

Summary

• River Global Investors LLP has reported beneficial ownership of 5,497,452 equity shares of MAXCYTE, INC.
• This stake represents 5.1568% of MAXCYTE, INC.'s outstanding equity class securities.
• The event triggering this Schedule 13D filing occurred on September 23, 2025.
• On September 23, 2025, River Global Investors LLP conducted purchase transactions for 252,702 shares, including 20,848 shares at USD1.7357, 143,999 shares at USD1.7390, and 87,755 shares at USD1.5486.

Sentiment

Score: 7

Explanation: The disclosure of a significant beneficial ownership stake by an institutional investor like River Global Investors LLP typically signals a vote of confidence in the issuer's value or future prospects.

Positives

• A significant institutional investor, River Global Investors LLP, has taken a 5.1568% stake in MAXCYTE, INC., which can be interpreted as a vote of confidence in the company's value and future prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Potential positive sentiment due to institutional investment, which may signal confidence in the company's future.

Key Dates

Keywords

MAXCYTE, River Global Investors, Schedule 13D, equity, beneficial ownership, institutional investment, stake, investment